Last updated: December 30, 2024
Sponsor: NYU Langone Health
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hearing Loss
Hearing Impairment
Deafness
Treatment
SEDA
Clinical Study ID
NCT05805384
22-00815
SB1DC018761
Ages > 12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
At least 12 years of age.
Be post-lingually deafened cochlear implant recipients with at least 6 monthsexperience regardless of manufacturer.
The PI must also deem the child to be developmentally able to complete theexperiments.
Exclusion
Exclusion Criteria:
• Anyone who is not a cochlear implant user or is aged under 12 years.
Study Design
Total Participants: 60
Treatment Group(s): 1
Primary Treatment: SEDA
Phase:
Study Start date:
March 01, 2023
Estimated Completion Date:
March 01, 2027
Connect with a study center
Tisch Hospital
New York, New York 10016
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.